MedTrace Logo

Persistent Atrial Fibrillation Ablation Trial

NCT01891825 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2014-06-26

No results posted yet for this study

Summary

Persistent atrial fibrillation (AF) is a common and distressing condition, that can cause significant symptoms. AF ablation is a recognised technique to treat persistent AF, but can be technically difficult. This study compares percutaneous ablation to thoracoscopic surgical AF ablation.

Conditions

Interventions

PROCEDURE

Surgical AF ablation

Minimally invasive thoracoscopic surgical ablation of atrial fibrillation

PROCEDURE

Percutaneous AF ablation

Percutaneous catheter ablation of atrial fibrillation

Sponsors & Collaborators

  • Neil Sulke

    lead OTHER

Principal Investigators

  • Neil Sulke, DM · Eastbourne General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2016-09-30
Completion
2016-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01891825 on ClinicalTrials.gov